Last reviewed · How we verify
NCT03046355: GROW
Timing of Delivery in Fetal Growth Restriction of Uncomplicated Women
NA trial testing Labor induction at 37.0 to 37.6 weeks of gestation in Fetal Growth Restriction in 21 participants. Completed in 18 March 2019.
18 March 2019
Quick facts
| Lead sponsor | The University of Texas Health Science Center, Houston |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 21 |
| Start date | 13 March 2017 |
| Primary completion | 18 March 2019 |
| Estimated completion | 18 March 2019 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- Labor induction at 37.0 to 37.6 weeks of gestation
- Expectant monitoring until delivery
Conditions studied
- Fetal Growth Restriction — all drugs for Fetal Growth Restriction →
Sponsor
The University of Texas Health Science Center, Houston
Who can join
Adults 18 to 39, female only, with Fetal Growth Restriction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of the study is to determine whether labor induction at 37 weeks of pregnancy can improve the baby's health at birth when compared with delivery at a later point in the pregnancy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03046355
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fetal Growth Restriction
Currently open trials in the same condition.
- NCT06919692 — Maternal Left Lateral Position in Fetal Growth Restriction · NA · recruiting
- NCT07015203 — The Combined First Trimester Screening · recruiting
- NCT06497959 — Study of Placental Vascularization Using Contrast Ultrasound · Phase 3 · recruiting
- NCT05674487 — Prostaglandins Versus Trans-cervical Balloon for Induction of Labor in Fetal Growth Restriction (PROBIN) · NA · recruiting
- NCT06372938 — Role of Inflammatory Markers and Doppler Parameters in Late-Onset Fetal Growth Restriction: A Machine Learning Approach · active not recruiting
Other The University of Texas Health Science Center, Houston trials
Trials by the same sponsor.
- NCT04200729 — Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-cente · Phase 4 · not yet recruiting
- NCT07225062 — Improving HIV Prevention and Substance Use Post-Sexual Assault Services · NA · not yet recruiting
- NCT07396974 — Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (RCT) · NA · not yet recruiting
- NCT07170163 — Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families · NA · not yet recruiting
- NCT06915441 — Lipid Infusions to Optimize Nutrition Trial · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03046355 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center, Houston
- Last refreshed: 13 June 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03046355.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing